Need professional-grade analysis? Visit stockanalysis.com
$19.80B
16.31
3,410
2.40%
Tonghua Dongbao Pharmaceutical Co Ltd (600867) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY10.15, down 2.50% from the previous close.
Over the past year, 600867 has traded between a low of CNY7.23 and a high of CNY10.49. The stock has gained 37.3% over this period. It is currently 40.4% above its 52-week low.
Tonghua Dongbao Pharmaceutical Co Ltd has a market capitalization of $19.80B, with a price-to-earnings ratio of 16.31 and a dividend yield of 2.40%.
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metformin hydrochloride tablets. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
Side-by-side comparison against top Healthcare peers.